Cerebral expression of metabotropic glutamate receptor subtype 5 in idiopathic autism spectrum disorder and fragile X syndrome: A pilot study

Authors

James Robert Brašić, The Johns Hopkins University
Ayon Nandi, The Johns Hopkins University
David S Russell, Institute for Neurodegenerative Disorders
Danna Jennings, Institute for Neurodegenerative Disorders
Olivier Barret, Institute for Neurodegenerative Disorders
Samuel D Martin, The Johns Hopkins University
Keith Slifer, The Johns Hopkins University
Thomas Sedlak, The Johns Hopkins University
John P Seibyl, Institute for Neurodegenerative Disorders
Dean F Wong, Washington University School of Medicine in St. Louis
Dejan B Budimirovic, The Johns Hopkins University

Journal

International Journal of Molecular Sciences

Publication Date

2021

Volume

22

Issue

6

First Page

2863

Document Type

Open Access Publication

DOI

10.3390/ijms22062863

Rights and Permissions

Brašić JR, Nandi A, Russell DS, et al. Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study. Int J Mol Sci. 2021;22(6):2863. Published 2021 Mar 11. doi:10.3390/ijms22062863

Recommended Citation

Brašić, James Robert; Nandi, Ayon; Russell, David S; Jennings, Danna; Barret, Olivier; Martin, Samuel D; Slifer, Keith; Sedlak, Thomas; Seibyl, John P; Wong, Dean F; and Budimirovic, Dejan B, "Cerebral expression of metabotropic glutamate receptor subtype 5 in idiopathic autism spectrum disorder and fragile X syndrome: A pilot study." International Journal of Molecular Sciences. 22, 6. 2863 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10207